packageSomatrogon

somatrogon

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Somatrogon is a long-acting growth hormone analogue used to treat growth disorders in children. It is authorised in the European Union as a newer medicine, and is also still under investigation for further uses.

Summary written by glm-5.3-flash from Wikidata Q110220159 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:somatrogon
ATC codes:H01AC08
DrugBank:DB14960
Wikidata:Q110220159
molar mass:30465.1 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown